Showing results (51-60 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|April 23, 2013
Effect of assay measurement error on parameter estimation in concentration-QTc interval modelingPeter L BonatePharmaceutical Statistics|June 5, 2013
Specifications of a continual reassessment method design for phase I trials of combined drugsNolan A Wages, Mark R ConawayPharmaceutical Statistics|July 31, 2013
A hybrid approach to achieving both marginal and conditional balances for stratification variables in sequential clinical trialsYunzhi Lin, Zheng SuPharmaceutical Statistics|June 19, 2013
Tests of marginal homogeneity and special casesKeith DunniganPharmaceutical Statistics|July 30, 2013
Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert groupAlan Phillips, Chrissie Fletcher, Gary Atkinson, et al.Pharmaceutical Statistics|May 17, 2012
Bonferroni-based correction factor for multiple, correlated endpointsQian Shi, Emily S Pavey, Rickey E CarterPharmaceutical Statistics|October 22, 2009
Missing data: discussion points from the PSI missing data expert groupTomasz Burzykowski, James Carpenter, Corneel Coens, et al.Pharmaceutical Statistics|December 24, 2009
Potential surrogate endpoints in cancer research--some considerations and examplesS W Duffy, F P TreasurePharmaceutical Statistics|November 3, 2017
A simple, doubly robust, efficient estimator for survival functions using pseudo observationsJixian WangPharmaceutical Statistics|November 3, 2017
The plan of enrichment designs for dealing with high placebo responseXiangmin Zhang, Yeh-Fong Chen, Roy TamuraPageof 119